Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial

Published:2022-10 Issue: Volume:52 Page:101596
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Tong Yeqing,Zhang Xinyue,Chen Jinhua,Chen Wei,Wang Zhao,Li Qiong,Duan Kai,Wei Sheng,Yang Beifang,Qian Xiaoai,Li Jiahong,Hang Lianju,Deng Shaoyong,Li Xinguo,Guo Changfu,Shen Heng,Liu Yan,Deng Peng,Xie Tingbo,Li Qingliang,Li Li,Du Hongqiao,Mao Qunying,Gao Fan,Lu Weiwei,Guan Xuhua,Huang Jiao,Li Xiuling,Chen Xiaoqi

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention;Esposito;Eur J Clin Microbiol Infect Dis,2018

2. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition);Li;World J Pediatr,2018

3. An apparently new enterovirus isolated from patients with disease of the central nervous system;Schmidt;J Infect Dis,1974

4. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study;Messacar;Lancet Infect Dis,2020

5. Risk factors for severe hand-foot-mouth disease in China: a systematic review and meta-analysis;Li;Front Pediatr,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness and impact of the enterovirus 71 vaccine on the onset of hand, foot, and mouth disease in children aged ≤5 years: A 7-year study;Journal of Infection;2024-10

2. Effectiveness of EV-A71 Vaccine and Its Impact on the Incidence of Hand, Foot and Mouth Disease: A Systematic Review;Vaccines;2024-09-08

3. Potential of a bivalent vaccine for broad protection against enterovirus 71 and coxsackie virus 16 infections causing hand, foot, and mouth disease;Vaccine;2023-09

4. Seroprevalence of human enterovirus A71 in Guangzhou, China, 2019–2021;Biosafety and Health;2023-06